MedPath

Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion

Phase 4
Completed
Conditions
Atrial Fibrillation
Interventions
Registration Number
NCT00232219
Lead Sponsor
Melbourne Health
Brief Summary

The purpose of this study is to investigate whether fish oil supplements may be beneficial in preventing the recurrence of atrial fibrillation after cardioversion.

Atrial fibrillation is a heart condition which can sometimes be successfully treated by a cardioversion.

Cardioversion involves resetting the heart back to normal with the use of electric current.

There is a tendency for the atrial fibrillation to recur , days weeks or even months after the cardioversion.

Fish oil supplements may be of benefit to patients with heart problems Recent evidence suggests that fish oils may be beneficial to patients with rhythm disturbances.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Patients with persistent Atrial Fibrillation on Warfarin.
Exclusion Criteria
  • paroxysmal atrial fibrillation with self terminating episodes.
  • left atrial size>6.0cm
  • myocardial infarction in the previous 6 months.
  • contraindications to amiodarone use .
  • cardiac surgery in the previous 3 months .
  • an acute reversible illness contributing to the development of af
  • a QTc interval > 480ms.
  • pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Fish oilFish oilPatients given 6g/day of fish oil containing 1.8g/d of EPA+DHA in a 1.5:1 ratio.
Primary Outcome Measures
NameTimeMethod
Recurrence of atrial fibrillation followed cardioversion1 year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Royal Melbourne hospital

🇦🇺

Melbourne, Victoria, Australia

© Copyright 2025. All Rights Reserved by MedPath